Barclays Maintains Overweight on Otis Worldwide, Lowers Price Target to $80
Barclays analyst Julian Mitchell maintains Otis Worldwide (NYSE:OTIS) with a Overweight and lowers the price target from $82 to $80.
Barclays Maintains Overweight on nVent Electric, Lowers Price Target to $43
Barclays analyst Julian Mitchell maintains nVent Electric (NYSE:NVT) with a Overweight and lowers the price target from $44 to $43.
Barclays Maintains Equal-Weight on Lennox International, Lowers Price Target to $230
Barclays analyst Julian Mitchell maintains Lennox International (NYSE:LII) with a Equal-Weight and lowers the price target from $240 to $230.
Raymond James Maintains Strong Buy on Agree Realty, Raises Price Target to $85
Raymond James analyst RJ Milligan maintains Agree Realty (NYSE:ADC) with a Strong Buy and raises the price target from $76 to $85.
Morgan Stanley Maintains Equal-Weight on Union Pacific, Lowers Price Target to $210
Morgan Stanley analyst Ravi Shanker maintains Union Pacific (NYSE:UNP) with a Equal-Weight and lowers the price target from $215 to $210.
Raymond James Maintains Outperform on CSX, Lowers Price Target to $35
Raymond James analyst Patrick Tyler Brown maintains CSX (NASDAQ:CSX) with a Outperform and lowers the price target from $40 to $35.
Barclays Maintains Overweight on Honeywell Intl, Lowers Price Target to $204
Barclays analyst Julian Mitchell maintains Honeywell Intl (NASDAQ:HON) with a Overweight and lowers the price target from $220 to $204.
Barclays Maintains Equal-Weight on Gates Industrial Corp, Lowers Price Target to $14
Barclays analyst Julian Mitchell maintains Gates Industrial Corp (NYSE:GTES) with a Equal-Weight and lowers the price target from $15 to $14.
Barclays Maintains Overweight on Fortive, Lowers Price Target to $68
Barclays analyst Julian Mitchell maintains Fortive (NYSE:FTV) with a Overweight and lowers the price target from $74 to $68.
Barclays Maintains Equal-Weight on Emerson Electric, Lowers Price Target to $80
Barclays analyst Julian Mitchell maintains Emerson Electric (NYSE:EMR) with a Equal-Weight and lowers the price target from $87 to $80.